Drug
Diagnostic Procedures
Diagnostic Procedures: highest development phase Post-Market, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Diagnostic procedures NCT00867815 | Post-Market | Anterior Ischemic Optic Neuropathy |
Latest
No recent events.
Follow Diagnostic Procedures on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.